[Pandemic scenarios].
Identifieur interne : 000418 ( Main/Exploration ); précédent : 000417; suivant : 000419[Pandemic scenarios].
Auteurs : Werner LangeSource :
- Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege [ 0723-2276 ] ; 2008.
Descripteurs français
- KwdFr :
- Adulte, Allemagne, Analyse de survie, Antiviraux (usage thérapeutique), Contrôle des maladies contagieuses (organisation et administration), Directives de santé publique, Flambées de maladies, Grippe humaine (), Grippe humaine (mortalité), Grippe humaine (soins infirmiers), Humains, Organisation mondiale de la santé, Planification en santé (organisation et administration), Sialidase (antagonistes et inhibiteurs), Sous-type H2N2 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- antagonistes et inhibiteurs : Sialidase.
- mortalité : Grippe humaine.
- organisation et administration : Contrôle des maladies contagieuses, Planification en santé.
- soins infirmiers : Grippe humaine.
- usage thérapeutique : Antiviraux.
- Adulte, Allemagne, Analyse de survie, Directives de santé publique, Flambées de maladies, Grippe humaine, Humains, Organisation mondiale de la santé, Sous-type H2N2 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adult, Antiviral Agents (therapeutic use), Communicable Disease Control (organization & administration), Disease Outbreaks, Germany, Health Planning (organization & administration), Health Planning Guidelines, Humans, Influenza A Virus, H2N2 Subtype, Influenza A Virus, H3N2 Subtype, Influenza Vaccines (administration & dosage), Influenza, Human (mortality), Influenza, Human (nursing), Influenza, Human (prevention & control), Neuraminidase (antagonists & inhibitors), Survival Analysis, World Health Organization.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , antagonists & inhibitors : Neuraminidase.
- chemical , therapeutic use : Antiviral Agents.
- geographic : Germany.
- mortality : Influenza, Human.
- nursing : Influenza, Human.
- organization & administration : Communicable Disease Control, Health Planning.
- prevention & control : Influenza, Human.
- Adult, Disease Outbreaks, Health Planning Guidelines, Humans, Influenza A Virus, H2N2 Subtype, Influenza A Virus, H3N2 Subtype, Survival Analysis, World Health Organization.
PubMed: 18561775
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Pandemic scenarios].</title><author><name sortKey="Lange, Werner" sort="Lange, Werner" uniqKey="Lange W" first="Werner" last="Lange">Werner Lange</name><affiliation><nlm:affiliation>Robert Koch Institutes, Influenza-Abteilung beim RKI.</nlm:affiliation><wicri:noCountry code="subField">Influenza-Abteilung beim RKI</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18561775</idno><idno type="pmid">18561775</idno><idno type="wicri:Area/Main/Corpus">000437</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000437</idno><idno type="wicri:Area/Main/Curation">000437</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000437</idno><idno type="wicri:Area/Main/Exploration">000437</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Pandemic scenarios].</title><author><name sortKey="Lange, Werner" sort="Lange, Werner" uniqKey="Lange W" first="Werner" last="Lange">Werner Lange</name><affiliation><nlm:affiliation>Robert Koch Institutes, Influenza-Abteilung beim RKI.</nlm:affiliation><wicri:noCountry code="subField">Influenza-Abteilung beim RKI</wicri:noCountry></affiliation></author></analytic><series><title level="j">Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege</title><idno type="ISSN">0723-2276</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antiviral Agents (therapeutic use)</term><term>Communicable Disease Control (organization & administration)</term><term>Disease Outbreaks</term><term>Germany</term><term>Health Planning (organization & administration)</term><term>Health Planning Guidelines</term><term>Humans</term><term>Influenza A Virus, H2N2 Subtype</term><term>Influenza A Virus, H3N2 Subtype</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (mortality)</term><term>Influenza, Human (nursing)</term><term>Influenza, Human (prevention & control)</term><term>Neuraminidase (antagonists & inhibitors)</term><term>Survival Analysis</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Allemagne</term><term>Analyse de survie</term><term>Antiviraux (usage thérapeutique)</term><term>Contrôle des maladies contagieuses (organisation et administration)</term><term>Directives de santé publique</term><term>Flambées de maladies</term><term>Grippe humaine ()</term><term>Grippe humaine (mortalité)</term><term>Grippe humaine (soins infirmiers)</term><term>Humains</term><term>Organisation mondiale de la santé</term><term>Planification en santé (organisation et administration)</term><term>Sialidase (antagonistes et inhibiteurs)</term><term>Sous-type H2N2 du virus de la grippe A</term><term>Sous-type H3N2 du virus de la grippe A</term><term>Vaccins antigrippaux (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neuraminidase</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Sialidase</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="nursing" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Contrôle des maladies contagieuses</term><term>Planification en santé</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term><term>Health Planning</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="soins infirmiers" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Disease Outbreaks</term><term>Health Planning Guidelines</term><term>Humans</term><term>Influenza A Virus, H2N2 Subtype</term><term>Influenza A Virus, H3N2 Subtype</term><term>Survival Analysis</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Allemagne</term><term>Analyse de survie</term><term>Directives de santé publique</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Humains</term><term>Organisation mondiale de la santé</term><term>Sous-type H2N2 du virus de la grippe A</term><term>Sous-type H3N2 du virus de la grippe A</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18561775</PMID><DateCompleted><Year>2008</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0723-2276</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2008</Year><Month>May</Month></PubDate></JournalIssue><Title>Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege</Title><ISOAbbreviation>Kinderkrankenschwester</ISOAbbreviation></Journal><ArticleTitle>[Pandemic scenarios].</ArticleTitle><Pagination><MedlinePgn>181-4</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Robert Koch Institutes, Influenza-Abteilung beim RKI.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Pandemien-Szenarien.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Kinderkrankenschwester</MedlineTA><NlmUniqueID>8305989</NlmUniqueID><ISSNLinking>0723-2276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber><NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006285" MajorTopicYN="N">Health Planning</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006287" MajorTopicYN="N">Health Planning Guidelines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053121" MajorTopicYN="Y">Influenza A Virus, H2N2 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="Y">Influenza A Virus, H3N2 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>6</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>7</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>6</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18561775</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Lange, Werner" sort="Lange, Werner" uniqKey="Lange W" first="Werner" last="Lange">Werner Lange</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000418 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000418 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18561775
|texte= [Pandemic scenarios].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18561775" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |